US2015011508A1PendingUtilityA1

Compounds and compositions as c-kit kinase inhibitors

Assignee: LIU XIAODONGPriority: Sep 1, 2011Filed: Aug 28, 2012Published: Jan 8, 2015
Est. expirySep 1, 2031(~5.1 yrs left)· nominal 20-yr term from priority
A61P 37/06A61P 9/12A61P 9/00A61P 3/10A61P 37/08A61P 43/00A61P 29/00A61P 3/00C07D 471/04A61P 11/00A61K 31/4245A61P 11/02A61P 17/00A61P 1/16A61P 17/04A61P 1/00C07F 9/6561A61P 11/06
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compounds of formulae (I) and (II) and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.

Claims

exact text as granted — not AI-modified
1 . A compound of Formula (I) or Formula (II), or a pharmaceutically acceptable salt thereof: 
       
         
           
           
               
               
           
         
         wherein:
 m is 1 and R 20  is selected from H, halo, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, deuterium, deuterated C 1 -C 6 alkyl, —CN, —(CR 9   2 ) n OR 4 , —C(O)R 4 , —(CR 9   2 ) n C(═O)OR 4 , R 8 , —(CR 9   2 ) n R 8 , —((CR 9   2 ) n O) t R 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n C(═O)R 4 , —C(═O)N(R 4 ) 2 , —N(R 4 ) 2 , —C(═S)N(R 4 ) 2 , —(CR 9   2 ) n OR 4 , —OW and —(CR 9   2 ) n CN, 
 or m is 4 and R 20  is deuterium; 
 R 1  is selected from C 1 -C 6 alkyl and halo; 
 each R 11  is independently selected from H, halo and C 1 -C 6 alkyl; 
 L 1  is a bond, —NH— or —C(O)NH—; 
 R 2  is selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 8 alkenyl, —(CR 9   2 ) n OR 4 , —(CR 9   2 ) n R 6 , —(CR 9   2 ) n S(═O) 2 NR 4   2 , —(CR 9   2 ) n CN, —(CR 9   2 ) n C(═O)R 4 , —(CR 9   2 ) n OC(═O)R 4 , —(CR 9   2 ) n C(═O)OR 4 , —(CR 9   2 ) n C(═O)NR 4   2 , —(CR 9   2 ) n OC(═)ONR 4 (CR 9   2 ) n OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n O(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n OCR 9 R 6 R 6 , —(CR 9   2 ) n CR 9 R 5 R 6 , —(CR 9   2 ) n CR 5 R 6 R 6 , —(CR 9   2 ) n CR 9 R 6 OC(O)(CR 9   2 ) n NR 4   2 , —(CR 9   2 ) n OC(O)(CR 9   2 ) n NR 4   2 , —CR 9 R 5 R 6 , —CR 9 R 9 R 5 , —CR 9 R 6 NR 4   2 , —(CR 9   2 ) n NR 4   2 , —NR 4 (CR 9   2 ) n OR 4 , —NR 4 (CR 9   2 ) n R 6 , —NR 4 (CR 9   2 ) n R 4 , —(CR 9   2 )NR 4 C(═O)R 4 , —(CR 9   2 ) n NR 4 C(═O)OR 4 , —(CR 9   2 )NR 4 C(═O)NR 4   2 , —(CR 9   2 )NR 4 C(═O)R 6 , —(CR 9   2 ) n NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n OR 4 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n OR 4 , —CR 5 R 5 NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 5 C(═O)R 6 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n R 6 , —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n R 11 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n O(CR 9   2 ) n R 6 , and —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n R 6 ; 
 each R 4  is independently selected from H and C 1 -C 6 alkyl; 
 each R 5  is independently selected from —NHC(O)OR 4 , —OP(O)(OR 4 ) 2  and —(CR 9   2 ) n OR 4 ; 
 each R 6  is a C 1 -C 6 haloalkyl; 
 each R 9  is independently selected from H and C 1 -C 6 alkyl; 
 R 8  is selected from an unsubstituted phenyl, unsubstituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, an unsubstituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted C 3 -C 8 cycloalkyl, a substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, a substituted phenyl, a substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, a substituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, a substituted C 3 -C 8 cycloalkyl, a oxazolidin-2-one, pyrrolidinone and a pyrrolidin-2-one,
 wherein the substituted phenyl, the substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, the substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, substituted C 3 -C 8 cycloalkyl and substituted 4-6 membered heterocycloalkyl of R 8  are substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, halo, —(C(R 9 ) 2 ) n OR 4 , —C(O)NR 4   2 —NR 4   2 , —R 10 , —(C(R 9 ) 2 ) n R 19 , —(C(R 9 ) 2 ) n C(O)OR 4 , —C(O)OR 4 , —(C(R 9 ) 2 ) n C(O)NR 4   2 , —C(O)NR 4 (C(R 9 ) 2 ) n R 19 , —(C(R 9 ) 2 ) n C(O)NR 4 (C(R 9 ) 2 ) n R 19 , —(C(R 9 ) 2 ) n C(O)NR 4 (C(R 9 ) 2 ) n OR 4 , —C(O)NR 4 (C(R 9 ) 2 ) n OR 4 , —C(O)OR 4 , —C(O)R 4  and —S(O) 2 R 4 ; 
 
 R 10  is selected from an unsubstituted phenyl, unsubstituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, an unsubstituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted C 3 -C 8 cycloalkyl, a substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, a substituted phenyl, a substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, a substituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, and a substituted C 3 -C 8 cycloalkyl,
 wherein the substituted phenyl, the substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, the substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, substituted C 3 -C 8 cycloalkyl and substituted 4-6 membered heterocycloalkyl of R 10  are substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, and —(C(R 9 ) 2 ) n OR 4 ; 
 
 t is 1, 2 or 3, and 
 each n is independently selected from 1, 2, 3 and 4. 
 
       
     
     
         2 . The compound of  claim 1  wherein:
 m is 1 and R 20  is selected from H, halo, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, deuterium, deuterated C 1 -C 6 alkyl, —CN, —(CR 9   2 ) n OR 4 , —C(O)R 4 , —(CR 9   2 ) n C(═O)OR 4 , R 8 , —(CR 9   2 ) n R 8 , —((CR 9   2 ) n O) t R 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n C(═O)R 4 , —C(═O)N(R 4 ) 2 , —(CR 9   2 ) n OR 4 , —OR 4  and —(CR 9   2 ) n CN, 
 or m is 4 and R 20  is deuterium; 
 R 1  is selected from C 1 -C 6 alkyl and halo; 
 each R 11  is independently selected from H, halo and C 1 -C 6 alkyl; 
 L 1  is a bond, —NH— or —C(O)NH—; 
 R 2  is selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 8 alkenyl, —(CR 9   2 ) n OR 4 , —(CR 9   2 ) n R 6 , —(CR 9   2 ) n S(═O) 2 NR 4   2 , —(CR 9   2 ) n CN, —(CR 9   2 ) n C(═O)R 4 , —(CR 9   2 ) n OC(═O)R 4 , —(CR 9   2 ) n C(═O)OR 4 , —(CR 9   2 ) n C(═O)NR 4   2 , —(CR 9   2 ) n OC(═O)NR 4 (CR 9   2 ) n OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n O(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n OCR 9 R 6 R 6 , —(CR 9   2 ) n CR 9 R 5 R 6 , —(CR 9   2 ) n CR 5 R 6 R 6 , —CR 9 R 5 R 6 , —CR 9 R 9 R 5 , —CR 9 R 6 NR 4   2 , —(CR 9   2 ) n NR 4   2 , —NR 4 (CR 9   2 ) n OR 4 , —NR 4 (CR 9   2 ) n R 6 , —NR 4 (CR 9   2 ) n R 4 , —(CR 9   2 )NR 4 C(═O)R 4 , —(CR 9   2 ) n NR 4 C(═O)OR 4 , —(CR 9   2 )NR 4 C(═O)NR 4   2 , —(CR 9   2 )NR 4 C(═O)R 6 , —(CR 9   2 ) n NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n OR 4 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n OR 4 , —CR 5 R 5 NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 5 C(═O)R 6 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n R 6 , —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n R 11 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n O(CR 9   2 ) n R 6 , and —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n R 6 ; 
 each R 4  is independently selected from H and C 1 -C 6 alkyl; 
 each R 5  is independently selected from —NHC(O)OR 4 , —OR 4  and —(CR 9   2 ) n OR 4 ; 
 each R 6  is a C 1 -C 6 haloalkyl; 
 each R 9  is independently selected from H and C 1 -C 6 alkyl; 
 R 8  is selected from an unsubstituted phenyl, unsubstituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, an unsubstituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted C 3 -C 8 cycloalkyl, a substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, a substituted phenyl, a substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, a substituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, a substituted C 3 -C 8 cycloalkyl, a oxazolidin-2-one, pyrrolidinone and a pyrrolidin-2-one,
 wherein the substituted phenyl, the substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, the substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, substituted C 3 -C 8 cycloalkyl and substituted 4-6 membered heterocycloalkyl of R 8  are substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, halo, —(C(R 9 ) 2 ) n OR 4 , —C(O)NR 4   2 —NR 4   2 , —R 10 , —(C(R 9 ) 2 ) n R 10 , —OR 4 , —(C(R 9 ) 2 ) n C(O)OR 4  and —S(O) 2 R 4 ; 
 
 R 10  is selected from an unsubstituted phenyl, unsubstituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, an unsubstituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted C 3 -C 8 cycloalkyl, a substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, a substituted phenyl, a substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, a substituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, and a substituted C 3 -C 8 cycloalkyl,
 wherein the substituted phenyl, the substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, the substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, substituted C 3 -C 8 cycloalkyl and substituted 4-6 membered heterocycloalkyl of R 10  are substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, and —(C(R 9 ) 2 ) n OR 4 ; 
 
 t is 1, 2 or 3, and 
 each n is independently selected from 1, 2, 3 and 4. 
 
     
     
         3 . The compound of  claim 1 , wherein the compound is a compound of Formula (Ia), Formula (IIa), Formula (Ib) or Formula (IIb): 
       
         
           
           
               
               
           
         
         wherein:
 m is 1 and R 20  is selected from H, halo, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 haloalkoxy, deuterium, deuterated C 1 -C 6 alkyl, —CN, —(CR 9   2 ) n OR 4 , —C(O)R 4 , —(CR 9   2 ) n C(═O)OR 4 , R 8 , —(CR 9   2 ) n R 8 , —((CR 9   2 ) n O) t R 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n C(═O)R 4 , —C(═O)N(R 4 ) 2 , —(CR 9   2 ) n OR 4 , —OR 4  and —(CR 9   2 ) n CN; 
 or m is 4 and R 20  is deuterium; 
 R 1  is selected from C 1 -C 6 alkyl and halo; 
 each R 11  is independently selected from H, halo and C 1 -C 6 alkyl; 
 R 2  is selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -C 8 alkenyl, —(CR 9   2 ) n OR 4 , —(CR 9   2 ) n R 6 , —(CR 9   2 ) n S(═O) 2 NR 4   2 , —(CR 9   2 ) n CN, —(CR 9   2 ) n C(═O)R 4 , —(CR 9   2 ) n OC(═O)R 4 , —(CR 9   2 ) n C(═O)OR 4 , —(CR 9   2 ) n C(═O)NR 4   2 , —(CR 9   2 ) n OC(═)ONR 4 (CR 9   2 ) n OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n O(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n OCR 9 R 6 R 6 , —(CR 9   2 ) n CR 9 R 5 R 6 , —(CR 9   2 ) n CR 5 R 6 R 6 , —CR 9 R 5 R 6 , —CR 9 R 9 R 5 , —CR 9 R 6 NR 4   2 , —(CR 9   2 ) n NR 4   2 , —NR 4 (CR 9   2 ) n OR 4 , —NR 4 (CR 9   2 ) n R 6 , —NR 4 (CR 9   2 ) n R 4 , —(CR 9   2 )NR 4 C(═O)R 4 , —(CR 9   2 ) n NR 4 C(═O)OR 4 , —(CR 9   2 )NR 4 C(═O)NR 4   2 , —(CR 9   2 )NR 4 C(═O)R 6 , —(CR 9   2 ) n NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n OR 4 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n OR 4 , —CR 5 R 5 NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 5 C(═O)R 6 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n R 6 , —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n R 11 , —(CR 9   2 ) n NR 4 C(═O)(CR 9   2 ) n O(CR 9   2 ) n R 6 , and —(CR 9   2 ) n NR 4 C(═O)O(CR 9   2 ) n R 6 ; 
 each R 4  is independently selected from H and C 1 -C 6 alkyl; 
 each R 5  is independently selected from —NHC(O)OR 4 , —OR 4  and —(CR 9   2 ) n OR 4 ; 
 each R 6  is a C 1 -C 6 haloalkyl; 
 each R 9  is independently selected from H and C 1 -C 6 alkyl; 
 R 8  is selected from an unsubstituted phenyl, unsubstituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, an unsubstituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted C 3 -C 8 cycloalkyl, a substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, a substituted phenyl, a substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, a substituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, a substituted C 3 -C 8 cycloalkyl, a oxazolidin-2-one, pyrrolidinone and a pyrrolidin-2-one,
 wherein the substituted phenyl, the substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, the substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, substituted C 3 -C 8 cycloalkyl and substituted 4-6 membered heterocycloalkyl of R 8  are substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, halo, —(C(R 9 ) 2 ) n OR 4 , —C(O)NR 4   2 —NR 4   2 , —R 10 , —(C(R 9 ) 2 ) n R 10 , —(C(R 9 ) 2 ) n C(O)OR 4  and —S(O) 2 R 4 ; 
 
 R 10  is selected from an unsubstituted phenyl, unsubstituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, an unsubstituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, an unsubstituted C 3 -C 8 cycloalkyl, a substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, a substituted phenyl, a substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, a substituted 4-6 membered heterocycloalkyl with 1-2 heteroatoms independently selected from N, O or S, and a substituted C 3 -C 8 cycloalkyl,
 wherein the substituted phenyl, the substituted 5-6 membered heteroaryl with 1-2 heteroatoms independently selected from N, O or S, the substituted 5 membered heteroaryl with 1-4 heteroatoms selected from N, substituted C 3 -C 8 cycloalkyl and substituted 4-6 membered heterocycloalkyl of R 10  are substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, and —(C(R 9 ) 2 ) n OR 4 ; 
 
 t is 1, 2 or 3, and 
 each n is independently selected from 1, 2, 3 and 4. 
 
       
     
     
         4 . The compound of  claim 1  wherein R 1  is selected from —CH 3  and F. 
     
     
         5 . The compound of  claim 1 , wherein R 1  is —CH 3 . 
     
     
         6 . The compound of  claim 1 , wherein each R 11  is independently selected from H, F and —CH 3 . 
     
     
         7 . The compound of  claim 1 , wherein each R 11  is H. 
     
     
         8 . The compound of  claim 1 , wherein:
 R 2  is selected from —(CR 9   2 ) n CN, —(CR 9   2 ) n NR 4 C(═O)OR 4 , —(CR 9   2 ) n OR 4 , —(CR 9   2 ) n C(═O)NR 4   2 , —(CR 9   2 ) n C(═O)R 4 , C 1 -C 6 alkyl, C 2 -C 8 alkenyl, —(CR 9   2 ) n CR 5 R 6 R 6 , —CR 5 R 5 NR 4 S(═O) 2 R 4 , —(CR 9   2 ) n NR 4 S(═O) 2 R 4 , —(CR 9   2 )NR 4 C(═O)R 6 , —(CR 9   2 ) n O(CR 9   2 ) n OR 4 , —(CR 9   2 ) n C(═O)OR 4 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n CR 9 R 5 R 6 , —NR 4 (CR 9   2 ) n R 6 , —NR 4 (CR 9   2 ) n R 4 , —(CR 9   2 ) n R 6  and —(CR 9   2 ) n OCR 9 R 6 R 6 .   
     
     
         9 . The compound of  claim 1 , wherein:
 R 2  is selected from —(CR 9   2 ) n CR 9 R 5 R 6  and —(CR 9   2 ) n OR 4 .   
     
     
         10 . The compound of  claim 1 , wherein each R 4  is independently selected from H, methyl, ethyl, propyl, butyl, i-propyl and t-butyl. 
     
     
         11 . The compound of  claim 1 , wherein each R 5  is independently selected from, —OR 4  and —(CR 9   2 ) n OR 4 . 
     
     
         12 . The compound of  claim 1 , wherein each R 5  is independently selected from OH and —CH 2 OH. 
     
     
         13 . The compound of  claim 1 , wherein each R 6  is independently selected from —CH 2 F, —CHF 2 , —CH 2 CHF 2 , —CH 2 CF 3  and —CF 3 . 
     
     
         14 . The compound of  claim 1 , wherein each R 9  is independently selected from H, methyl and ethyl. 
     
     
         15 . (canceled) 
     
     
         16 . The compound of  claim 1 , wherein R 2  is —C(CH 3 ) 2 CH 2 OH or —CH 2 CH 2 C(CH 3 )OHCF 3 . 
     
     
         17 . The compound of  claim 1  wherein m is 1 and R 20  is selected from H, halo, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, deuterated C 1 -C 6 alkyl, —CN, —(CR 9   2 ) n OR 4 , —R 8 , —(CR 9   2 ) n R 8 , —(CR 9   2 ) n O(CR 9   2 ) n R 6 , —(CR 9   2 ) n C(═O)R 4 , —(CR 9   2 ) n OR 4  and —OR 4 . 
     
     
         18 . The compound of  claim 1 , wherein m is 1 and R 20  is selected from H, —F, —CH 3 , —CF 3 , —CD 3 , —CN, —OCHF 2 , —CH 2 CH 2 C(CH 3 ) 2 OH, —CH 2 OCH 2 CF 3 , —CH 2 CH 2 C(═O)CH 3 , —CH 2 OCH 3  and —OCH 3 . 
     
     
         19 . The compound of  claim 1 , wherein m is 1 and R 20  is H or —CH 3 . 
     
     
         20 . (canceled) 
     
     
         21 . (canceled) 
     
     
         22 . The compound of  claim 1 , wherein:
 R 8  is selected from phenyl, morpholinyl, cyclopropyl, pyridinyl, pyridine-3-yl, pyridine-4-yl, pyrazolyl, pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrrolyl, triazolyl, 1H-1,2,3-triazol-4-yl, 4H-1,2,4-triazol-3-yl, 1H-1,2,4-triazol-5-yl, thiazolyl, thiazol-4-yl, thiazol-5-yl, isoxazolyl and isoxazol-4-yl, each of which is unsubstituted or each of which is substituted with 1-3 substituents independently selected from F, —CH 3 , —C(CH 3 ) 2 CH 2 OH, —CH 2 OCH 3 , —C(O)NHCH 3 , —NH 2  and —OCH 3 .   
     
     
         23 . (canceled) 
     
     
         24 . The compound of  claim 1  selected from:
 N-{5-[5-(2-cyanoethyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl N-{2-[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl}carbamate; 
 N-{5-[5-(3-methoxypropyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{5-[2-(diethylcarbamoyl)ethyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(3-oxobutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 ethyl 2-[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]acetate; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxybutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(2-ethoxyethyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl N-[(1S)-1-[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethyl]carbamate; 
 N-(5-{5-[(1R)-1-methoxyethyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(2-methyl-5-{5-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(1,3-dihydroxy-2-methanesulfonamidopropan-2-yl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{5-[(1R)-1-methanesulfonamidoethyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}-N-methylcarbamate; 
 N-{5-[5-(ethanesulfonamidomethyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl N-ethyl-N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 N-(5-{5-[(N-ethylmethanesulfonamido)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 methyl N-ethyl-N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 N-(2-methyl-5-{5-[(2,2,2-trifluoroacetamido)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(propane-2-sulfonamidomethyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{5-[(2-methoxyethoxy)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl 2-[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]acetate; 
 N-(2-methyl-5-{5-[2-(2,2,2-trifluoroethoxy)ethyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 ethyl N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 propan-2-yl N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 N-(2-methyl-5-{5-[(2R)-3,3,3-trifluoro-2-hydroxypropyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{5-[(2-ethoxyethoxy)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-{[2-(propan-2-yloxy)ethoxy]methyl}-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[5-(5-{[2-(tert-butoxy)ethoxy]methyl}-1,2,4-oxadiazol-3-yl)-2-methylphenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(2-methyl-5-{5-[(3,3,3-trifluoropropanamido)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-fluoro-N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 6-fluoro-N-(5-{5-[(2-methoxyethoxy)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 ethyl N-{[3-(3-{6-fluoroimidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 N-(2-methyl-5-{5-[(2,2,2-trifluoroethoxy)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 2,2-difluoroethyl N-{[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]methyl}carbamate; 
 methyl N-({3-[4-methyl-3-(7-{1-[2-(morpholin-4-yl)ethyl]-1H-pyrazol-4-yl}imidazo[1,2-a]pyridine-3-amido)phenyl]-1,2,4-oxadiazol-5-yl}methyl)carbamate; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-7-(1-methyl-1H-pyrazol-3-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(1-methyl-1H-pyrazol-4-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-[1-(2-hydroxy-2-methylpropyl)-1H-pyrazol-4-yl]-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{[5-(1-hydroxy-2-methylpropan-2-yl)-1,2,4-oxadiazol-3-yl]amino}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-(1,3-thiazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(2,4-dimethyl-1,3-thiazol-5-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-7-methylimidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-{1-[2-(morpholin-4-yl)ethyl]-1H-pyrazol-4-yl}imidazo[1,2-a]pyridine-3-carboxamide; 
 5,6,7,8-tetradeutero-N-{2-methyl-5-[5-(3-methylbut-2-en-1-yl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 5,6,7,8-tetradeutero-N-(5-{5-[(2-methoxyethoxy)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 5,6,7,8-tetradeutero-N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 propan-2-yl 3-[3-(3-{imidazo[1,2-a]pyridine-3-amido}-4-methylphenyl)-1,2,4-oxadiazol-5-yl]propanoate; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-6-methoxyimidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl}-2-methylphenyl]-6-methylimidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{5-[(2-methoxyethoxy)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)-6-methylimidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(pentan-2-yl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-7-(morpholin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-7-(2-oxo-1,3-oxazolidin-3-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-7-(2-oxopyrrolidin-1-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}-7-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-cyclopropyl-N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 7-fluoro-N-(5-{5-[(2-hydroxy-2-methylpropyl)(methyl)amino]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(5-{5-[(2-fluoroethyl)amino]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)-7-methylimidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(2-methylpropyl)amino]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-fluoro-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 6-fluoro-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 6-methyl-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 5,6,7,8-tetradeutero-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(3,3,3-trifluoropropyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(3S)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(2,2,2-trifluoroethoxy)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(2,2,2-trifluoroethoxy)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-methyl-N-(2-methyl-5-{5-[(2,2,2-trifluoroethoxy)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{2-methyl-5-[5-(4,4,4-trifluorobutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-(2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-(2-methylpyridin-3-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-(3-methylpyridin-4-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-methyl-N-(2-methyl-5-{5-[(3S)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-fluoro-N-(2-methyl-5-{5-[(3S)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-fluoro-N-(2-methyl-5-{5-[(3S)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-methyl-N-(2-methyl-5-{5-[(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-fluoro-N-(2-methyl-5-{5-[(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-fluoro-N-(2-methyl-5-{5-[(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-methoxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(2,4-dimethyl-1,3-thiazol-5-yl)-N-(2-methyl-5-{5-[(2,2,2-trifluoroethoxy)methyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(2-fluoropyridin-3-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)pyridine-2-carboxamide; 
 N-(5-{5-[(2,2-difluoroethoxy)methyl]-1,2,4-oxadiazol-3-yl}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-{5-(5-{[(1,3-difluoropropan-2-yl)oxy]methyl}-1,2,4-oxadiazol-3-yl)-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-{[(1,1,1-trifluoropropan-2-yl)oxy]methyl}-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(4-methyl-1,3-thiazol-5-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxybutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(2R)-3,3,3-trifluoro-2-hydroxypropyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-6-(1,3,5-trimethyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(1-methyl-1H-pyrrol-2-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(4-methoxypyridin-3-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(2-aminopyridin-4-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 tert-butyl 2-[3,5-dimethyl-4-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1H-pyrazol-1-yl]acetate; 
 6-[5-(1-hydroxyethyl)-4-methyl-1,3-thiazol-2-yl]-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(4,5-dimethyl-1,3-thiazol-2-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(1-{[(2-hydroxyethyl)carbamoyl]methyl}-3,5-dimethyl-1H-pyrazol-4-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-[3,5-dimethyl-1-({[2-(morpholin-4-yl)ethyl]carbamoyl}methyl)-1H-pyrazol-4-yl]-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-carbamothioyl-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(2-hydroxyethyl)-4-methyl-2-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-5-carboxamide; 
 4-methyl-2-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]-1,3-thiazole-5-carboxamide; 
 4-methyl-2-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-N-[3-(4-methylpiperazin-1-yl)propyl]-1,3-thiazole-5-carboxamide; 
 4-methyl-2-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-5-carboxamide; 
 8-amino-N-{5-[5-(3-hydroxy-3-methylbutyl)-1,2,4-oxadiazol-3-yl]-2-methylphenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 4-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-2-carboxylic acid; 
 4-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-N-[2-(4-methylpiperazin-1-yl)ethyl]-1,3-thiazole-2-carboxamide; 
 2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl2-aminoacetate; 
 (2R)-1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl(2R)-2-amino-3-methylbutanoate; 
 (2S)-1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl (2R)-2-amino-3-methylbutanoate; 
 7-methyl-N-{2-methyl-5-[5-(4,4,4-trifluoro-3-hydroxybutyl)-1,2,4-oxadiazol-3-yl]phenyl}imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 6-[1-(2-hydroxyethyl)-3,5-dimethyl-1H-pyrazol-4-yl]-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(5-acetyl-4-methyl-1,3-thiazol-2-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 6-(3-methyl-1H-pyrazol-4-yl)-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N,4-dimethyl-2-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-5-carboxamide; 
 4-methyl-2-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-5-carboxamide; 
 6-{3,5-dimethyl-1-[(methylcarbamoyl)methyl]-1H-pyrazol-4-yl}-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 ethyl 4-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-2-carboxylate; 
 4-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-N-[2-(morpholin-4-yl)ethyl]-1,3-thiazole-2-carboxamide; 
 N-(2-hydroxyethyl)-4-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-2-carboxamide; 
 4-methyl-5-(3-{[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbamoyl}imidazo[1,2-a]pyridin-6-yl)-1,3-thiazole-2-carboxamide; 
 6-[2-(hydroxymethyl)-4-methyl-1,3-thiazol-5-yl]-N-[2-methyl-5-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]imidazo[1,2-a]pyridine-3-carboxamide; 
 N-(2-methyl-5-{5-[1-(2,2,2-trifluoroethoxy)ethyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 dimethyl (2R)-1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl phosphate; 
 {[(2R)-1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl]oxy}phosphonic acid; 
 dimethyl (2S)-1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl phosphate; 
 {[(2S)-1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl]oxy}phosphonic acid, and 
 1,1,1-trifluoro-2-methyl-4-[3-(4-methyl-3-{7-methylimidazo[1,2-a]pyridine-3-amido}phenyl)-1,2,4-oxadiazol-5-yl]butan-2-yl (2S)-2-aminopropanoate. 
 
     
     
         25 . The compound of  claim 1  selected from:
 N-(5-{[5-(1-hydroxy-2-methylpropan-2-yl)-1,2,4-oxadiazol-3-yl]amino}-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide; 
 7-methyl-N-(2-methyl-5-{5-[(3S)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide, and 
 7-methyl-N-(2-methyl-5-{5-[(3R)-4,4,4-trifluoro-3-hydroxy-3-methylbutyl]-1,2,4-oxadiazol-3-yl}phenyl)imidazo[1,2-a]pyridine-3-carboxamide. 
 
     
     
         26 . A pharmaceutical composition comprising a therapeutically effective amount a compound of  claim 1  and a pharmaceutically acceptable carrier. 
     
     
         27 . (canceled) 
     
     
         28 . (canceled) 
     
     
         29 . (canceled) 
     
     
         30 . (canceled) 
     
     
         31 . (canceled) 
     
     
         32 . (canceled) 
     
     
         33 . (canceled) 
     
     
         34 . (canceled) 
     
     
         35 . (canceled)

Join the waitlist — get patent alerts

Track US2015011508A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.